+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Bulky Hodgkins disease Treatment with an initial 7-drug chemotherapy delivered over 12 weeks followed by high-dose Extended Field irradiation Seven-year results of the GOELAMS H90M multicentric randomized trial



Bulky Hodgkins disease Treatment with an initial 7-drug chemotherapy delivered over 12 weeks followed by high-dose Extended Field irradiation Seven-year results of the GOELAMS H90M multicentric randomized trial



Blood 94(10 SUPPL 1 PART 1): 528a, Nov 15




(PDF emailed within 1 workday: $29.90)

Accession: 034509661

Download citation: RISBibTeXText


Related references

Treatment of CS IA to IIIB non-bulky Hodgkins disease with 3 cycles of chemotherapy followed by high dose irradiation Results of the goelams H90-NM multicenter randomized trial. Blood 94(10 SUPPL 1 PART 1): 386a, Nov 15, 1999

High-risk Hodgkins disease ABVD chemotherapy followed by beam-conditioned autologous stem cell transplantation and focal radiotherapy versus intensive chemotherapy followed by involved field RT Two-year results of the Goelams H97-GM multicentric randomized trial. Blood 96(11 Part 1): 791a, November 16, 2000

Very High Risk Hodgkins Disease ABVD Plus BEAM Followed by Autologous Stem Cell Transplantation and Radiotherapy Versus Intensive Chemotherapy and RT Interim Results of the GOELAMS H97-GM Multicentric Randomized Trial. Blood 100(11): Abstract No 811, November 16, 2002

Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial. Cancer 95(10): 2169-2179, 2002

Hodgkins disease in children treatment results with mechlorethamine vincristine procarbazine prednisone and low dose extended field irradiation. Cancer Treatment Reports 66(4): 949-960, 1982

Frontline High-Dose Chemotherapy with Autologous Stem Cell Transplantation vs Standard CHOP Regimen for Patients with Non IPI High-Risk Intermediate or High-Grade Lymphomas Final Results of a Randomized Trial by the GOELAMS. Blood 100(11): Abstract No 675, November 16, 2002

Sequential chemotherapy and involved-field radiotherapy for rescue treatment of Hodgkins disease with initial bulky mediastinal involvement. British Journal of Haematology 93(SUPPL 2): 366, 1996

Final results of a randomized trial 30 Gy extended field plus 10 Gy involved field radiation in equally effective to 40 Gy extended field radiation in patients with Hodgkins disease PS I/II. Blood 90(10 SUPPL 1 PART 1): 585A, Nov 15, 1997

Prospective randomized trial in the treatment of early stage Hodgkins disease using involved field radiation therapy vs subtotal nodal irradiation after a short chemotherapy course. European Journal of Cancer 37(Supplement 6): S89-S90, October, 2001

Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group. Cancer 113(12): 3323-3330, 2008

HD-RI First results of a randomized trial comparing aggressive chemotherapy with high-dose therapy and hematopoietic stem cell transplantation in patients with chemosensitive relapse of Hodgkins disease. Blood 90(10 SUPPL 1 PART 1): 115A, Nov 15, 1997

High-dose therapy autotransplantation/intensification vs continued conventional chemotherapy in multiple myeloma patients responding to initial treatment chemotherapy Results of a prospective randomized trial from the Spanish Cooperative Group PETHEMA. Blood 98(11 Part 1): 815a, November 16, 2001

Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 274(5): 387-393, 1995

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL). Annals of Oncology 17(10): 1546-1552, 2006

Prospective randomized trial in combined modality treatment of intermediate risk Hodgkins disease using extended field vs involved field radiation therapy. International Journal of Radiation Oncology Biology Physics 45(3 SUPPL ): 215-216, 1999